Literature DB >> 31699787

Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease.

Elvezia Maria Paraboschi1,2, Amit Vikram Khera3,4,5, Piera Angelica Merlini6, Laura Gigante7, Flora Peyvandi8,9, Mark Chaffin3,4,5, Marzia Menegatti8, Fabiana Busti10, Domenico Girelli10, Nicola Martinelli10, Oliviero Olivieri10, Sekar Kathiresan3,4,5, Diego Ardissino7, Rosanna Asselta1,2, Stefano Duga1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31699787      PMCID： PMC7327651          DOI： 10.3324/haematol.2019.237750

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Rivaroxaban in patients with a recent acute coronary syndrome.

Authors:  Jessica L Mega; Eugene Braunwald; Stephen D Wiviott; Jean-Pierre Bassand; Deepak L Bhatt; Christoph Bode; Paul Burton; Marc Cohen; Nancy Cook-Bruns; Keith A A Fox; Shinya Goto; Sabina A Murphy; Alexei N Plotnikov; David Schneider; Xiang Sun; Freek W A Verheugt; C Michael Gibson
Journal:  N Engl J Med       Date:  2011-11-13       Impact factor: 91.245

Review 2.  Protease-activated receptor 2 signaling in inflammation.

Authors:  Andrea S Rothmeier; Wolfram Ruf
Journal:  Semin Immunopathol       Date:  2011-10-06       Impact factor: 9.623

3.  Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice.

Authors:  Tomoya Hara; Daiju Fukuda; Kimie Tanaka; Yasutomi Higashikuni; Yoichiro Hirata; Sachiko Nishimoto; Shusuke Yagi; Hirotsugu Yamada; Takeshi Soeki; Tetsuzo Wakatsuki; Michio Shimabukuro; Masataka Sata
Journal:  Atherosclerosis       Date:  2015-03-19       Impact factor: 5.162

Review 4.  Role of oral factor Xa inhibitors after acute coronary syndrome.

Authors:  Abhishek Sharma; Akash Garg; Jeffrey S Borer; Parasuram Krishnamoorthy; Jalaj Garg; Carl J Lavie; Armin Arbab-Zadeh; Debabrata Mukherjee; Hasan Ahmad; Edgar Lichstein
Journal:  Cardiology       Date:  2014-11-07       Impact factor: 1.869

Review 5.  Acute coronary events.

Authors:  Armin Arbab-Zadeh; Masataka Nakano; Renu Virmani; Valentin Fuster
Journal:  Circulation       Date:  2012-03-06       Impact factor: 29.690

6.  Oral rivaroxaban for symptomatic venous thromboembolism.

Authors:  Rupert Bauersachs; Scott D Berkowitz; Benjamin Brenner; Harry R Buller; Hervé Decousus; Alex S Gallus; Anthonie W Lensing; Frank Misselwitz; Martin H Prins; Gary E Raskob; Annelise Segers; Peter Verhamme; Phil Wells; Giancarlo Agnelli; Henri Bounameaux; Alexander Cohen; Bruce L Davidson; Franco Piovella; Sebastian Schellong
Journal:  N Engl J Med       Date:  2010-12-03       Impact factor: 91.245

Review 7.  Genetics of Common, Complex Coronary Artery Disease.

Authors:  Kiran Musunuru; Sekar Kathiresan
Journal:  Cell       Date:  2019-03-21       Impact factor: 41.582

8.  Coagulation factor Xa stimulates interleukin-8 release in endothelial cells and mononuclear leukocytes: implications in acute myocardial infarction.

Authors:  Gabi Busch; Isabell Seitz; Birgit Steppich; Sibylle Hess; Robert Eckl; Albert Schömig; Ilka Ott
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-11-18       Impact factor: 8.311

9.  Early atherosclerosis exhibits an enhanced procoagulant state.

Authors:  Julian Ilcheff Borissoff; Sylvia Heeneman; Evren Kilinç; Peter Kassák; René Van Oerle; Kristien Winckers; José W P Govers-Riemslag; Karly Hamulyák; Tilman M Hackeng; Mat J A P Daemen; Hugo ten Cate; Henri M H Spronk
Journal:  Circulation       Date:  2010-08-09       Impact factor: 29.690

10.  Local Production of Activated Factor X in Atherosclerotic Plaque Induced Vascular Smooth Muscle Cell Senescence.

Authors:  Fumihiro Sanada; Jun Muratsu; Rei Otsu; Hideo Shimizu; Nobutaka Koibuchi; Kazutaka Uchida; Yoshiaki Taniyama; Shinichi Yoshimura; Hiromi Rakugi; Ryuichi Morishita
Journal:  Sci Rep       Date:  2017-12-07       Impact factor: 4.379
View more
  4 in total

1.  Rare, Damaging DNA Variants in CORIN and Risk of Coronary Artery Disease: Insights From Functional Genomics and Large-Scale Sequencing Analyses.

Authors:  Minxian Wang; Vivian S Lee-Kim; Deepak S Atri; Nadine H Elowe; John Yu; Colin W Garvie; Hong-Hee Won; Joseph E Hadaya; Bryan T MacDonald; Kevin Trindade; Olle Melander; Daniel J Rader; Pradeep Natarajan; Sekar Kathiresan; Virendar K Kaushik; Amit V Khera; Rajat M Gupta
Journal:  Circ Genom Precis Med       Date:  2021-10-01

Review 2.  Gene-Environment Interactions for Cardiovascular Disease.

Authors:  Jaana A Hartiala; James R Hilser; Subarna Biswas; Aldons J Lusis; Hooman Allayee
Journal:  Curr Atheroscler Rep       Date:  2021-10-14       Impact factor: 5.967

3.  ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy.

Authors:  Rosanna Asselta; Elvezia Maria Paraboschi; Alberto Mantovani; Stefano Duga
Journal:  Aging (Albany NY)       Date:  2020-06-05       Impact factor: 5.682

4.  Use of a Genetic Variant Related to Circulating FXa (Activated Factor X) Levels to Proxy the Effect of FXa Inhibition on Cardiovascular Outcomes.

Authors:  Dipender Gill; Stephen Burgess
Journal:  Circ Genom Precis Med       Date:  2020-08-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.